Myasthenia Gravis Clinical Trials Myasthenia Gravis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Open-label Study to Determine the Maximum Tolerated Dose of MuSK-CAART for MuSK Myasthenia Gravis
Condition:   MuSK Myasthenia Gravis Intervention:   Biological: MuSK-CAART Sponsor:   Cabaletta Bio Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2022 Category: Research Source Type: clinical trials